Observation on the effect of sequential psychological intervention combined with body position management in patients with primary liver cancer undergoing hepatic arterial infusion chemotherapy

This study aims to observe the effect of sequential psychological intervention combined with body position management on patients diagnosed with primary liver cancer undergoing hepatic arterial infusion chemotherapy (HAIC). A cohort of 108 male patients diagnosed with primary hepatocellular carcinoma, undergoing HAIC at the Department of Oncology in our hospital between February 2022 and January 2024, were retrospectively selected. Patients admitted between February 2022 and January 2023 were included in the control group, while patients admitted between February 2023 and January 2024 were included in the observation group. The control group was treated with routine care, and the observation group received sequential psychological intervention combined with body position management. We compared their psychological status, perceived stress levels, incidence of adverse reactions, and overall comfort levels between the two groups before and after nursing interventions. After nursing interventions, the scores across all dimensions of the Depression Anxiety and Stress Scale (DASS-21) were lower in both the intervention and control groups compared to baseline, with the observation group demonstrating significantly lower scores in the perceived stress scale ((12.11 ± 3.20) points) compared to the control group ((17.12± 3.39) points) (p < 0.001). Furthermore, there were statistically significant differences observed in the incidence of adverse reactions and comfort between the two groups (p < 0.001). Sequential psychological intervention combined with body position management demonstrated superior nursing efficacy for male patients undergoing HAIC for primary liver cancer, effectively enhanced psychological well-being, mitigated perceived stress and reduced the occurrence of adverse reactions.

Sequential psychological care; Body position management; Hepatic arterial infusion chemotherapy; Psychological status

[1] Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nature Reviews Cancer. 2021; 21: 541–557.

[2] Iwamoto H, Shimose S, Shirono T, Niizeki T, Kawaguchi T. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity. Clinical and Molecular Hepatology. 2023; 29: 593–604.

[3] Datta J, Narayan RR, Kemeny NE, D’Angelica MI. Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review. JAMA Surgery. 2019; 154: 768–776.

[4] Li S, Xu J, Zhang H, Hong J, Si Y, Yang T, et al. The role of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Chemotherapy. 2021; 66: 124–133.

[5] Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. Journal of Clinical Oncology. 2019; 37: 2899–2915.

[6] Taylor RS, Long L, Mordi IR, Madsen MT, Davies EJ, Dalal H, et al. Exercise-based rehabilitation for heart failure: Cochrane systematic review, meta-analysis, and trial sequential analysis. JACC: Heart Failure. 2019; 7: 691–705.

[7] Wan Y, Chen B, Li N, Yang JY, Dai HT, Tang KY. et al. Transradial versus transfemoral access for patients with liver cancer undergoing hepatic arterial infusion chemotherapy: patient experience and procedural complications. Journal of Vascular and Interventional Radiology: JVIR. 2022; 33: 956–963.e1.

[8] Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 Edition). Liver cancer. 2020; 9: 682–720.

[9] González-Rivera JA, Pagán-Torres OM, Pérez-Torres EM. Depression, anxiety and stress scales (DASS-21): construct validity problem in Hispanics. European journal of Investigation in Health, Psychology and Education. 2020; 10: 375–389.

[10] Chan SF, La Greca AM. Perceived stress scale (PSS). Encyclopedia of Behavioral Medicine. 2020; 29: 1646–1648.

[11] Gavelin HM, Dong C, Minkov R, Bahar-Fuchs A, Ellis KA, Lautenschlager NT, et al. Combined physical and cognitive training for older adults with and without cognitive impairment: a systematic review and network meta-analysis of randomized controlled trials. Ageing Research Reviews. 2021; 66: 101232.

[12] Wang T, Dong J, Zhang Y, Ren Z, Liu Y, Yang X, et al. Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort study. Annals of Translational Medicine. 2022; 10: 411.

[13] Pan Y, Mei J, Chen J, Zhang D, Wang J, Wang X, et al. Comparison between portal vein perfusion chemotherapy and neoadjuvant hepatic arterial infusion chemotherapy for resectable intermediate to advanced stage hepatocellular carcinoma. Annals of surgical oncology. 2022; 29: 2016–2029.

[14] Xiong J, Zhou Y, Tan K, Liu H, Cao Y, Liu J, et al. The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective study. Journal of gastrointestinal oncology. 2023; 14: 1830–1836.

[15] Feng J, Ge L, Jin F, Jiang L. Application of narrative nursing combined with focused solution model to anxiety and depression in patients with lung tumor during perioperative period. Frontiers in Surgery. 2022; 9: 858506.

[16] Claasen MPAW, Ivanics T, Beumer BR, de Wilde RF, Polak WG, Sapisochin G, et al. An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma☆. JHEP Reports. 2023; 5: 100745.

[17] Zhang X, Zhang H, Zhang Z, Fan H, Li S. The Mediating Effect of Resilience on the Relationship Between Symptom Burden and Anxiety/Depression Among Chinese Patients with Primary Liver Cancer After Liver Resection. Patient Preference and Adherence. 2023: 3033–3043.

[18] Li Q, Xu X, Xu F, Zhang X, Zhang L. Application effect of preoperative chemoradiotherapy combined with rehabilitation nursing in patients with rectal cancer surgery. To be published in Biotechnology & Genetic Engineering Reviews. 2023. [Preprint].

[19] Greten TF, Abou-Alfa GK, Cheng AL, Duffy AG, El-Khoueiry AB, Finn RS, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma. Journal for Immunotherapy of Cancer. 2021; 9: e002794.

[20] Hien PN, Chun HJ, Oh JS, Kim SH, Choi BG. Usefulness of tumor perfusion on cone-beam CT after hepatic arterial infusion port implantation for evaluating tumor response to hepatic arterial infusion chemotherapy in hepatocellular carcinoma treatment. Diagnostic and Interventional Radiology. 2023; 29: 832–837.

[21] Graf J, Stengel A. Psychological burden and psycho-oncological interventions for patients with hepatobiliary cancers-a systematic review. Frontiers in psychology. 2021; 12: 662777.

[22] Cong L, Xu XJ, Yu J, Wang G. Effects of percutaneous liver ablation combined with psychological intervention on postoperative recurrence, psychological stress, anxiety and depression in patients with liver cancer. Archives of Clinical Psychiatry. 2023; 50: 139–144.

[23] Fan S, Eiser C, Ho M. Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clinical Gastroenterology and Hepatology. 2010; 8: 559–564.e1–10.

[24] Nam HC, Sung PS, Chun HJ, Kim DG, Jang JW, Choi JY, et al. Liver transplantation after successful downstaging with hepatic arterial infusion chemotherapy in a patient with hepatocellular carcinoma with portal vein tumor thrombus. Journal of Liver Cancer. 2019; 19: 64–68.

[25] Chaudhry S, Fields RC, Grierson PM, Lim K H. Combined systemic and hepatic artery infusion pump chemotherapy as a liver-directed therapy for colorectal liver metastasis—review of literature and case discussion. Cancers. 2021; 13: 1283.